We
report a method of fabrication of fluorescent magnetosomes, designated
as MCR400, in which 400 μM of rhodamine B are introduced in
the growth medium of AMB-1 magnetotactic bacteria and fluorescent
magnetosomes are then extracted from these bacteria. These fluorescent
magnetosomes behave differently from most fluorescent nanoprobes,
which often lead to fluorescence losses over time due to photobleaching.
Indeed, when MCR400 are heated to 30–90 °C, brought to
an acidic pH, or exposed to radiations, we observed that their fluorescence
intensity increased. We attributed this behavior to the dissociation
of rhodamine B from the magnetosomes. Interestingly, enhanced fluorescence
was also observed in vitro when MCR400 were mixed with either primary
macrophages or tumor cells (TC1-GFP or RG2-Cells) or in vivo when
MCR400 were introduced in rat glioblastoma. We showed that MCR400
internalize in tumor and immune cells (macrophages) leading to enhanced
fluorescence, suggesting that fluorescent magnetosomes could be used
during cancer treatments such as magnetic hyperthermia to image cells
of interest such as immune or tumor cells.